Parkinson’s Disease Research News

Researchers have pinpointed how brain activity changes in mouse models of Parkinson's disease, providing clues as to what may drive symptoms of the disease in humans. ... read more

Researchers pinpoint how brain activity changes in mouse models of Parkinson's disease, hinting at what may drive symptoms in humans. ... read more

(Rana Healthcare Solutions LLC) Shimmer, a global leader in wearable technology for research applications, today launched Verisense™, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participants. Verisense is a comprehensive and flexible solution for reliably capturing accurate and ... read more

(Okinawa Institute of Science and Technology (OIST) Graduate University) Researchers pinpoint how brain activity changes in mouse models of Parkinson's disease, hinting at what may drive symptoms in humans. ... read more

A new review examines the past, present, and future of stem cell therapy for replacing damaged brain cells in Parkinson's disease. ... read more

  Recently researchers have proposed an interesting idea for why Parkinson’s is a distinctly human condition: There are parts of our brains that have not kept up with evolution, and as we live longer those ... read more

A new study reports high cholesterol may contribute to the risk of developing ALS. The findings suggest cholesterol lowering drugs, such as statins, could help to prevent the onsite of the neurodegenerative disease. ... read more

Researchers report on how new advances in stem cell biology and genetic engineering could be beneficial in developing new treatments for Parkinson's disease. ... read more

Researchers may have solved one of the great mysteries of neuroscience; namely, why neurons in the temporal lobe are the first to die in Alzheimer's disease, and why dopaminergic neurons are damaged first in Parkinson's. ... read more

(University of Virginia Health System) One of the great mysteries of neuroscience may finally have an answer: Scientists have identified a potential explanation for the mysterious death of specific brain cells seen in Alzheimer's, Parkinson's and other neurodegenerative diseases. ... read more

The most common PD treatment today is based on enhancing the activity of the nigro-striatal pathway in the brain with dopamine-modulating therapies, thereby increasing striatal dopamine levels and improving motor impairment associated with the disease. However, this treatment has significant long-term limitations and side effects. Stem cell technologies show promise ... read more

(IOS Press) Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson's disease (PD) in future. Writing in a special supplement to the Journal of Parkinson's Disease, experts describe how newly developed stem cell technologies could be used to treat the disease and discuss the great ... read more

PD is a slowly progressive disorder that affects movement, muscle control, and balance. “Our understanding of PD pathophysiology has vastly improved compared to what we knew 20 years ago,” explained authors Tom Foltynie, MBBS, PhD, Department of Clinical and Movement Neurosciences, UCL Institute of Neurology & The National Hospital for ... read more

(IOS Press) Understanding of the processes involved in Parkinson's disease (PD) degeneration has vastly improved over the last 20 years. In this insightful review, published in the special supplement to the Journal of Parkinson's Disease, experts consider which of the existing strategies to slow down or stop the degenerative processes ... read more

A review of existing research has examined the evidence for a connection between the gastrointestinal system and the progression of Parkinson's disease. ... read more

Over the last few years, there has been a growing body of research – and tremendous interest – focused on the role/influence of the gastrointestinal system in Parkinson’s. In today’s post we are ... read more

Researcher review the evidence that Parkinson's disease may, at least for some patients, begin in the gut. ... read more

PD is a slowly progressive disorder that affects movement, muscle control, and balance. In the last 20 years it has become clear that PD is associated with a number of gastrointestinal symptoms originating from functional and structural changes in the gut and its associated neural structures. Many patients with PD ... read more

(IOS Press) There is growing evidence that at least in some patients with Parkinson's disease (PD), the disease may begin in the gut. Writing in a special supplement to the Journal of Parkinson's Disease, experts explore the last two decades of research about the gut-brain axis in PD and look ... read more

Researchers have developed a neurofeedback system which allows Parkinson's patients to voluntarily control beta wave activity in the subthalamic nucleus. ... read more

Researchers report a drug commonly used to help treat HIV can significantly reduce age related inflammation in mice. The study suggests the drug could hold promise for treating age related disorders including Alzheimer's disease, type 2 diabetes and Parkinson's disease. ... read more

(Osaka University) A study group at Osaka University developed a neurofeedback system which enables patients with Parkinson's disease to voluntarily control beta waves in their deep brain associated with symptoms of the disorder. They demonstrated that patients can voluntary control beta waves. ... read more

Researchers report they have found no statistically significant evidence to back up previous claims the antidepressant Trazodone reduces dementia risks, when compared to other antidepressants. ... read more

PD is a slowly progressive disorder that affects movement, muscle control, and balance. “Brilliant work of many in different scientific fields has paved the way for the concept of prodromal PD; that is, a phase of years to decades in which non-motor and subtle motor symptoms may indicate spreading PD ... read more

(IOS Press) In the past 25 years it has become clear that some symptoms of Parkinson's disease (PD) occur decades before the development of motor symptoms and clinical diagnosis, and that monitoring these emerging symptoms may provide important insights into the origin and development of the disease. Understanding this 'prodromal' ... read more